Results 41 to 50 of about 483,075 (169)
Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis
BackgroundImmune checkpoints target regulatory pathways in T cells that enhance antitumor immune responses and elicit durable clinical responses. As a novel immune checkpoint, CD96 is an attractive key target for cancer immunotherapy.
Qiang Zhang +6 more
doaj +1 more source
Matrix metalloproteinases (MMPs) released from infiltrating immune cells are a major contributor to blood-brain barrier (BBB) breakdown following stroke.
Yejie Shi +13 more
doaj +1 more source
Huimin Wu,1,* Anxing Huang,2,* Keke Jiang,2,* Xiuping Wei,1 Zhi Ma,1 Haibo Jiang,1 Lili Xu,1 Wenya Lan,1 Mingyang Du,1 Hui Cao,1 Shanshan Chen,2 Xingjian Lin,2 Feng Qiu11Department of Cerebrovascular Disease Center, Affiliated ...
Wu H +12 more
doaj
PurposeInflammation and dyslipidemia are critical in post-stroke prognosis. We conducted a comprehensive analysis of six common inflammatory-lipid indices to evaluate the associations between these indices and four clinical outcomes after mechanical ...
Ao Qian +4 more
doaj +1 more source
BackgroundFerroptosis has recently been recognised as an immunogenic form of regulated cell death. Nicotinamide phosphoribosyltransferase (NAMPT), a key enzyme in the NAD+ salvage pathway, is highly expressed in glioblastoma and represents a promising ...
Dongxu Zhao +11 more
doaj +1 more source
Yan Yang,1,2 Xiuxia Shi,3 Yuanzheng Zhang,4 Xinmin Song,1 Xiaojie Zhang1 1Cerebrovascular Disease Treatment Center, Tianjin Fifth Central Hospital, Tianjin, People’s Republic of China; 2The Fifth Central Clinical College of Tianjin Medical University ...
Yang Y, Shi X, Zhang Y, Song X, Zhang X
doaj
Alzheimer’s disease (AD) and ischemic stroke (IS) are prevalent neurological disorders that frequently co-occur in the same individuals. Recent studies have demonstrated that AD and IS share several common risk factors and pathogenic elements, including ...
Wei Dong, Wei Wang, Mingxuan Li
doaj +1 more source
Background Recombinant tissue plasminogen activator (rtPA) remains the main therapeutic for acute ischemic stroke (AIS). In clinical practice, the patients with AIS presenting low response to rtPA is commonly observed. Cognizant that the endothelial cell
Yilin Wang +11 more
doaj +1 more source
Microsurgical treatment of intracranial dural arteriovenous fistula and prognosis analysis
Objective: To summarize and analyze the curative effect of 46 patients with intracranial dural arteriovenous fistula (DAVF) treated by microsurgery, explore the prognostic factors of DAVF, and summarize the skills and experience of surgical treatment ...
Lijiu Chen +5 more
doaj +1 more source
Predictors of Mortality in Posterior Circulation Ischemic Stroke
Background and Objectives: Posterior circulation ischemic stroke (PCIS) is a life-threatening disease with a poor prognosis. It has nonspecific symptoms. It is very difficult to diagnose.
Sanja Rsovac Ivanović +8 more
doaj +1 more source

